Divisadero Street Capital Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$1.18M 124
2025
Q4
$1.18M Buy
100,000
+84,504
+545% +$912K 0.06% 73
2025
Q3
$120K Buy
+15,496
New +$109K 0.01% 164

Other funds holding NEO

Divisadero Street Capital Management's NEO Position: Q1 2026 in Review

Divisadero Street Capital Management sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 100,000 shares — an estimated $1.18M sold.

Divisadero Street Capital Management first reported a position in NEO in Q3 2025 and held it in 2 quarters. The position peaked at $1.18M in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Divisadero Street Capital Management reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Divisadero Street Capital Management sold 100,000 NeoGenomics shares in Q1 2026, an estimated $1.18M.
  • Divisadero Street Capital Management first reported a position in NeoGenomics in Q3 2025 and held it in 2 quarters.
  • Divisadero Street Capital Management's NeoGenomics position peaked at $1.18M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Divisadero Street Capital Management's 13F filing for Q1 2026, filed 15 May 2026.